T cell immunosenescence in vitro and in vivo

被引:66
|
作者
Pawelec, G [1 ]
Wagner, W [1 ]
Adibzadeh, M [1 ]
Engel, A [1 ]
机构
[1] Univ Tubingen, Med Klin & Poliklin,Dept Internal Med 2, Tubingen Ageing & Tumour Immunol Grp, Sect Transplantat Immunol & Immunohaematol, D-72076 Tubingen, Germany
关键词
T cell longevity in vitro; T cell aging in vivo; DNA damage and repair; mitotic inhibitors; telomere attrition; apoptosis; cytokine secretion; CD28;
D O I
10.1016/S0531-5565(99)00002-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The term "immunosenescence" refers to an age-associated dysregulation of immune function which contributes to the increased susceptibility of the elderly to infectious disease. Although there are age-associated changes measurable in the innate immune system (Pawelec et al., 1998c), it is the adaptive, particularly T cell, system which is most susceptible to the deleterious effects of aging. In this minireview, characteristics of aging in long-term human T cell cultures will be summarized, and the parallels between the in vitro model and in vivo immunosenescence will be documented. The use of culture models to screen for ways of manipulating immunosenescence in vitro may provide a basis for intervention to ameliorate immunosenescence in vivo. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:419 / 429
页数:11
相关论文
共 50 条
  • [1] T cell dependent bronchoconstriction in vivo and in vitro
    Mori, A.
    Kitamura, N.
    Ohtomo, T.
    Abe, A.
    Kaminuma, O.
    ALLERGY, 2010, 65 : 69 - 69
  • [2] T cell immunosenescence, hypertension, and arterial stiffness
    Yu, Hee Tae
    Shin, Eui-Cheol
    EPIDEMIOLOGY AND HEALTH, 2014, 36
  • [3] Human T cell immunosenescence and inflammation in aging
    Bektas, Arsun
    Schurman, Shepherd H.
    Sen, Ranjan
    Ferrucci, Luigi
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (04) : 977 - 988
  • [4] Efalizumab induces T cell hyporesponsiveness in vivo and in vitro
    Koszik, F.
    Stary, G.
    Selenko-Gebauer, N.
    Stingl, G.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 294 - 294
  • [5] T cell hyporesponsiveness is induced by efalizumab in vivo and in vitro
    Koszik, F.
    Stary, G.
    Selenko-Gebauer, N.
    Stingl, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S114 - S114
  • [6] Reversing T cell immunosenescence: why, who, and how
    Lang, Pierre Olivier
    Govind, Sheila
    Aspinall, Richard
    AGE, 2013, 35 (03) : 609 - 620
  • [7] Reversing T cell immunosenescence: why, who, and how
    Pierre Olivier Lang
    Sheila Govind
    Richard Aspinall
    AGE, 2013, 35 : 609 - 620
  • [8] T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
    Shirakawa, Kohsuke
    Sano, Motoaki
    CELLS, 2021, 10 (09)
  • [9] DECLINE IN CD28(+) T-CELLS IN CENTENARIANS AND IN LONG-TERM T-CELL CULTURES - A POSSIBLE CAUSE FOR BOTH IN-VIVO AND IN-VITRO IMMUNOSENESCENCE
    EFFROS, RB
    BOUCHER, N
    PORTER, V
    ZHU, XM
    SPAULDING, C
    WALFORD, RL
    KRONENBERG, M
    COHEN, D
    SCHACHTER, F
    EXPERIMENTAL GERONTOLOGY, 1994, 29 (06) : 601 - 609
  • [10] Regulatory monocytes control T cell responses in vitro and in vivo
    Varga, G.
    Ehrchen, J. M.
    Tsianakas, A.
    Roebrock, K.
    Nippe, N.
    Stadtbaeumer, A.
    Roth, J.
    Sunderkoetter, C.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 300 - 300